Frontiers in Biomedicine: Prof. Marc Donath

Frontiers in Biomedicine: Prof. Marc Donath

02.12.2021 12:30 – 13:30

Pr Marc Y. Donath
Division of endocrinology, diabetology & metabolism, University Hospital Basel

«Islet inflammation: physiology, pathology and treatment»

Morphological and therapeutic interventions have uncovered an inflammatory process in patients with type 2 diabetes. This inflammation is due to a pathological activation of the innate immune system by metabolic stress and is largely governed by IL-1 signaling. Initially, the inflammatory response is probably deployed to promote adaptation and regeneration. Indeed, we identified a role for IL-1β and insulin in the regulation of both metabolism and immunity in response to feeding. Yet, as it becomes chronic, activation of auto-inflammatory processes may then become deleterious. It follows that modulation of inflammatory mediators may present as a possible causal therapy. This is supported by clinical studies showing that IL-1 antagonism decreases glycated hemoglobin. Furthermore, IL-1 antagonism prevents heart failure and cardiovascular diseases, the major complication of diabetes.


Bâtiment: CMU

Auditoire Alex-F. Müller (A250)

Organisé par

Faculté de médecine
Centre facultaire du diabète
Evénements de la Faculté de médecine

entrée libre


Catégorie: Séminaire

Mots clés: Faculté de médecine, Frontiers in Biomedicine, diabetes

Plus d'infos

Contact: missing email

Fichiers joints

afficheA3_FIB_Donath_2.pdf126.9 Kb